Skip to NavigationSkip to content

Ablynx appoints Robert Zeldin as new chief medical officer

Published on: 30/11/15

Ablynx has appointed Dr Robert Zeldin as chief medical officer (CMO) effective from 1 December 2015. 

Dr Zeldin will lead the the UK/Belgian firm in its global clinical development, regulatory and medical affairs activities, whilst bringing significant industry experience to the company. He has held senior level clinical development positions at top tier pharmaceutical companies, including Merck & Novartis.   

In his previous roles, Dr Zeldin headed teams in immunology, respiratory, dermatology and cardiovascular disease where he was responsible for clinical development through to commercialisation and life cycle management. He also successfully engaged key stakeholders including the scientific community, payers, patient advocacy groups and key opinion leaders. 

Prior to his move into pharma, Dr Zeldin spent several years in private practice and two years as a medical officer at the FDA's Center for Biologics Evaluation and Research. At the FDA he evaluated safety and efficacy data from all phases of clinical development. 

Commenting on his appointment, Dr Zeldin says: "Ablynx has a late stage clinical portfolio of promising innovative product candidates based on its unique and powerful nanobody technology. I am excited to be joining the company at this key stage in its development, and look forward to working with the team to bring new medicines to the market, which have the potential to meaningfully improve patients' lives."

Dr Zeldin holds a medical doctor degree from the Tufts University School of Medicine in Boston. He completed internship and residency in internal medicine at the University Health Center of Pittsburgh and is a fellow in allergy and clinical immunology at the Johns Hopkins University School of Medicine.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches